Methoxisopropamine
Legal status | |
---|---|
Legal status |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
Chemical and physical data | |
Formula | C16H23NO2 |
Molar mass | 261.365 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
MXiPr (Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine') is a recreational designer drug with dissociative effects. It is an arylcyclohexylamine derivative, related to drugs such as ketamine and methoxetamine. It was first identified in Slovenia in December 2020,[1] and was made illegal in Hungary in April 2021.[2]
See also
References
- ↑ "Analytical Report for MXiPr" (PDF). National Forensic Laboratory, Police, Ministry of the Interior. Republic of Slovenia.
(2‐(3‐methoxyphenyl)‐2‐[(propan‐2‐yl)amino]cyclohexan‐1‐one C16H23NO2)
- ↑ "Amendment of Decree No 55/2014 of 30 December 2014 on substances or groups of compounds classified as new psychoactive substances". Minister for Human Capacities. Government of Hungary. 2021/225/HU.
Glutamate receptor modulators | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sigma receptor modulators | |
---|---|
σ1 |
|
σ2 |
|
Unsorted |
|
See also: Receptor/signaling modulators |
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.